Technology
Health
Medical
ImmuCell
$6.919876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$6.91
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
+$0.06 (0.81%) Today
$0.00 (0.00%) After Hours
Why Robinhood?
You can buy or sell ImmuCell and other stocks, options, ETFs, and crypto commission-free!
About
ImmuCell Corp. engages in the development, acquisition, manufacture and sale of products that improve the health and productivity of cows for the dairy and beef industries. Its products include first defense for scours, California mastitis test kit and purified nisin intramammary treatment for mastitis. Read More The company was founded in 1982 and is headquartered in Portland, ME.
Employees
47
Headquarters
Portland, Maine
Founded
1982
Market Cap
37.87M
Price-Earnings Ratio
—
Dividend Yield
0.00
Average Volume
5.44K
High Today
$6.94
Low Today
$6.94
Open Price
$6.94
Volume
3.00
52 Week High
$9.30
52 Week Low
$6.38
Collections
Technology
Health
Medical
Defense
US
North America
News
Guru FocusMar 22
ImmuCell Corp (ICCC) Files 10-K for the Fiscal Year Ended on December 31, 2018
ImmuCell Corp (NASDAQ:ICCC) files its latest 10-K with SEC for the fiscal year ended on December 31, 2018. ImmuCell Corp is engaged in the development, acquisition, manufacture and sale of products that improve the health and productivity of cows for the dairy and beef industries.
Price Paid on Robinhood
6% Lower
Right Now
52 Week Low
$6.38
Average Price Paid
$7.38
52 Week High
$9.30
Earnings
-$0.19
-$0.13
-$0.06
$0.00
Q2 2017
Q3 2017
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Estimated
—
Actual
Expected May 13, After Hours